2,8-Dibenzyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one(CAS: 70217-82-2)

2,8-Dibenzyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one is subject to various regulatory guidelines including GHS classification for its hazardous properties, REACH regulations for its registration, evaluation, and authorization in the European Union, and FDA/EPA requirements for its use in pharmaceuticals and environmental applications.

Alternative reagents for synthesizing 2,8-Dibenzyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one include various benzyl compounds and imidazopyrazine precursors. Isomers and analogs such as 2,8-diaryl-6-phenylimidazo[1,2-a]pyrazines can also be used as substitutes.

The market for 2,8-Dibenzyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one is expanding in pharmaceuticals and research due to its anti-inflammatory and anti-cancer properties. Research trends include exploring its use in targeted drug delivery systems and as a lead compound in drug discovery.

Waste containing 2,8-Dibenzyl-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one should be collected in sealed containers and stored in a cool, well-ventilated area away from sources of ignition. For disposal, professional waste management services should be employed to ensure safe incineration or other environmentally friendly methods are used.